252 related articles for article (PubMed ID: 29742740)
21. The role of lactate deshydrogenase levels on non-small cell lung cancer prognosis: a meta-analysis.
Gong T; Liu J; Jiang J; Zhai YF; Wu CM; Ma C; Wen BL; Yan XY; Zhang X; Wang DM; Lu Q; Qu YL
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):89-93. PubMed ID: 30782303
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis.
Zhang N; Zhang H; Zhu D; JiRiGaLa ; Yu D; Wang C; WuYunBiLiGe ; Amin ; ZhiHong ; Yu H; Chen X; Wang M
Int J Surg; 2020 Jul; 79():66-73. PubMed ID: 32417461
[TBL] [Abstract][Full Text] [Related]
23. Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.
Zhang Z; Li Y; Yan X; Song Q; Wang G; Hu Y; Jiao S; Wang J
Cancer Med; 2019 Apr; 8(4):1467-1473. PubMed ID: 30848091
[TBL] [Abstract][Full Text] [Related]
24. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
25. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
Liu R; Cao J; Gao X; Zhang J; Wang L; Wang B; Guo L; Hu X; Wang Z
Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
[TBL] [Abstract][Full Text] [Related]
26. The relationship between the expression of Ki-67 and the prognosis of osteosarcoma.
Zeng M; Zhou J; Wen L; Zhu Y; Luo Y; Wang W
BMC Cancer; 2021 Mar; 21(1):210. PubMed ID: 33648449
[TBL] [Abstract][Full Text] [Related]
27. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.
Chen XY; Chen JY; Chen Y; Chen JF; Lin N; Ding CY; Kang DZ; Wang DL; Fang WH
Clin Neurol Neurosurg; 2021 Oct; 209():106912. PubMed ID: 34509141
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data.
Li H; Min D; Zhao H; Wang Z; Qi W; Zheng S; Tang L; He A; Sun Y; Yao Y; Shen Z
PLoS One; 2013; 8(6):e64513. PubMed ID: 23805177
[TBL] [Abstract][Full Text] [Related]
29. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
Qin J; Ke B; Liu T; Kong C; Li A; Fu H; Jin C
Cancer Med; 2023 Feb; 12(3):2199-2218. PubMed ID: 36057947
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Role of Serum Lactate Dehydrogenase in Patients With Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Wu M; Lin P; Xu L; Yu Z; Chen Q; Gu H; Liu C
Front Oncol; 2020; 10():677. PubMed ID: 32509573
[No Abstract] [Full Text] [Related]
31. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
32. Is preoperative serum lactate dehydrogenase useful in predicting the outcomes of patients with upper tract urothelial carcinoma?
Tan P; Chen J; Xie N; Xu H; Ai J; Xu H; Liu L; Yang L; Wei Q
Cancer Med; 2018 Oct; 7(10):5096-5106. PubMed ID: 30151961
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Serum Lactate Dehydrogenase in Patients with Nasopharyngeal Carcinoma: a Meta-Analysis.
Zhai C; Gu K; Zhai X; Wang J; Zhang J
Clin Lab; 2017 Nov; 63(11):1777-1785. PubMed ID: 29226643
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
[TBL] [Abstract][Full Text] [Related]
38. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma.
Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM
Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245
[TBL] [Abstract][Full Text] [Related]
39. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
40. Serum lactate dehydrogenase (LDH) as a tumor marker in Ewing's sarcoma.
Bacci G; Avella M; McDonald D; Toni A; Orlandi M; Campanacci M
Tumori; 1988 Dec; 74(6):649-55. PubMed ID: 3232209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]